How many actually read the article?
The institute, known by its French acronym INESSS, recommends only using chloroquine and hydroxychloroquine on a case-by-case basis for COVID-19 patients whose symptoms are more severe — such as those in intensive care.
Some studies have shown that the drugs have antiviral capabilities.
"The uncertainty surrounding the efficacy and safety of these treatments does not support the widespread use of chloroquine or hydroxychloroquine, regardless of the stage of the disease,"
__________________
Only dead fish go with the flow. The rest use their brains in life.
Originally Posted by Twisted Canuck
I wasn't thinking far enough ahead for an outcome, I was ranting. By definition, a rant doesn't imply much forethought.....
|